Compare CTSO & HOVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTSO | HOVR |
|---|---|---|
| Founded | 1997 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.7M | 80.5M |
| IPO Year | 2008 | N/A |
| Metric | CTSO | HOVR |
|---|---|---|
| Price | $0.73 | $1.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $5.38 | ★ $10.33 |
| AVG Volume (30 Days) | 67.1K | ★ 474.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $22,503,908.00 | N/A |
| Revenue This Year | $7.29 | N/A |
| Revenue Next Year | $8.91 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 48.53 | N/A |
| 52 Week Low | $0.60 | $0.35 |
| 52 Week High | $1.39 | $4.18 |
| Indicator | CTSO | HOVR |
|---|---|---|
| Relative Strength Index (RSI) | 54.78 | 49.18 |
| Support Level | $0.62 | $1.69 |
| Resistance Level | $0.84 | $2.07 |
| Average True Range (ATR) | 0.04 | 0.14 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 59.46 | 52.86 |
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and building a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities, and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, floods, and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.